Michael S. Rafii

9.4k total citations · 6 hit papers
112 papers, 4.8k citations indexed

About

Michael S. Rafii is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Psychiatry and Mental health. According to data from OpenAlex, Michael S. Rafii has authored 112 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Physiology, 41 papers in Public Health, Environmental and Occupational Health and 40 papers in Psychiatry and Mental health. Recurrent topics in Michael S. Rafii's work include Down syndrome and intellectual disability research (39 papers), Alzheimer's disease research and treatments (39 papers) and Dementia and Cognitive Impairment Research (35 papers). Michael S. Rafii is often cited by papers focused on Down syndrome and intellectual disability research (39 papers), Alzheimer's disease research and treatments (39 papers) and Dementia and Cognitive Impairment Research (35 papers). Michael S. Rafii collaborates with scholars based in United States, United Kingdom and Spain. Michael S. Rafii's co-authors include Paul Aisen, Paul Aisen, Robert A. Rissman, Michael Donohue, Rema Raman, Reisa A. Sperling, Brian G. Skotko, André Strydom, Diana W. Bianchi and Stephanie L. Sherman and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Michael S. Rafii

106 papers receiving 4.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

2024 776 citations Clifford R. Jack, Eric McDade et al. Alzheimer s & Dementia profile →
Down syndrome

2020 491 citations Michael S. Rafii, André Strydom et al. profile →
Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

2020 266 citations Rema Raman, Michael S. Rafii et al. profile →
Trial of Solanezumab in Preclinical Alzheimer’s Disease

2023 186 citations Reisa A. Sperling, Michael Donohue et al. New England Journal of Medicine profile →
Alzheimer's disease associated with Down syndrome: a genetic form of dementia

2021 170 citations Juan Fortea, Shahid Zaman et al. profile →
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease

2022 130 citations Michael S. Rafii, Reisa A. Sperling et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Michael S. Rafii

Since Specialization

Citations

This map shows the geographic impact of Michael S. Rafii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Rafii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Rafii more than expected).

Fields of papers citing papers by Michael S. Rafii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Rafii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Rafii. The network helps show where Michael S. Rafii may publish in the future.

Co-authorship network of co-authors of Michael S. Rafii

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Rafii. A scholar is included among the top collaborators of Michael S. Rafii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Rafii. Michael S. Rafii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials 2025 ·The Journal of Prevention of Alzheimer s Disease ·Gustavo Jimenez‐Maggiora, Michael Donohue, Michael S. Rafii, Rema Raman, Paul Aisen	1
2	CTAD taskforce: genetic therapies in Alzheimer’s disease 2025 ·The Journal of Prevention of Alzheimer s Disease ·David Jakabek, Adrian M. Isaacs, Bart De Strooper, Mark H. Tuszynski, Roger Lane, (unknown), Eric McDade, Michael S. Rafii, Catherine J. Mummery	1
3	Brain–heart–eye axis revealed by multi-organ imaging genetics and proteomics 2025 ·Nature Biomedical Engineering ·Andrew Zalesky, Ye Tian, Luigi Ferrucci, Wenjia Bai, Michael S. Rafii, Paul Aisen, Jian Zeng, (unknown), Filippos Anagnostakis, Michael R. Duggan, (unknown), Arthur W. Toga, Zhijian Yang, Keenan A. Walker, Christos Davatzikos, Junhao Wen	1
4	Clinical and neuropathological analysis of Down syndrome over 7 decades of life 2024 ·Journal of Neuropathology & Experimental Neurology ·Sonal Sukreet, (unknown), Jennifer Ngolab, (unknown), (unknown), (unknown), Michael S. Rafii, Annie Hiniker, Robert A. Rissman	1
5	Neuroimaging abnormalities associated with immunotherapy responsiveness in Down syndrome regression disorder 2024 ·Annals of Clinical and Translational Neurology ·Jonathan D. Santoro, (unknown), Saba Jafarpour, (unknown), Natalie K. Boyd, (unknown), Ryan Kammeyer, Lina Patel, Melanie A. Manning, Angela L. Rachubinski, Robyn A. Filipink, Nicole Baumer, Stephanie L. Santoro, Catherine Franklin, Benita Tamrazi, Kristen W. Yeom, Gordon Worley, Joaquı́n M. Espinosa, Michael S. Rafii	4
6	Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder 2024 ·Scientific Reports ·Jonathan D. Santoro, Saba Jafarpour, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Melanie Manning, (unknown), (unknown), Aaron D. Besterman, (unknown), Michael S. Rafii	1
7	From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach 2024 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Sonal Sukreet, Michael S. Rafii, Robert A. Rissman	9
8	The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down's syndrome 2024 ·Alzheimer s & Dementia ·Anna H. Boerwinkle, Julie K. Wisch, Benjamin L. Handen, Elizabeth Head, Mark Mapstone, Michael S. Rafii, Sid E. O’Bryant, Sharon J. Krinsky‐McHale, Florence Lai, H. Diana Rosas, Shahid Zaman, Ira T. Lott, Dana Tudorascu, Matthew Zammit, Adam M. Brickman, Joseph H. Lee, Beau M. Ances	5
9	Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease 2024 ·The Journal of Prevention of Alzheimer s Disease ·Zahra Shirzadi, Aaron P. Schultz, Michael J Properzi, R. Yaari, (unknown), Adam M. Brickman, Michael S. Rafii, Michael Donohue, Karin Ernström, (unknown), Clifford R. Jack, Steven M. Greenberg, Rema Raman, Paul Aisen, (unknown), Jasmeer P. Chhatwal	5
10	The Alzheimer's Disease Neuroimaging Initiative Clinical Core 2024 ·Alzheimer s & Dementia ·Paul Aisen, Michael Donohue, Rema Raman, Michael S. Rafii, Ronald C. Petersen, (unknown)	6
11	Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease 2023 ·Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring ·Dobri Baldaranov, (unknown), Garrett Miller, Michael Donohue, Leslie M. Shaw, Mike Weiner, Ronald C. Petersen, Paul Aisen, Rema Raman, Michael S. Rafii	8
12	Hypovitaminosis D in persons with Down syndrome and autism spectrum disorder 2023 ·Journal of Neurodevelopmental Disorders ·(unknown), Julia Nguyen, (unknown), (unknown), (unknown), (unknown), (unknown), Melanie A. Manning, Michael S. Rafii, Jonathan D. Santoro	2
13	Trial of Solanezumab in Preclinical Alzheimer’s Disease breakdown → 2023 ·New England Journal of Medicine ·Reisa A. Sperling, Michael Donohue, Rema Raman, Michael S. Rafii, Keith Johnson, Colin L. Masters, Christopher H. van Dyck, Takeshi Iwatsubo, Gad A. Marshall, R. Yaari, Michele Mancini, Karen C. Holdridge, Michael Case, John R. Sims, Paul Aisen	186
14	Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working group 2022 ·Journal of Neurodevelopmental Disorders ·Nicole Baumer, Mara L. Becker, George T. Capone, Kathleen M. Egan, Juan Fortea, Benjamin L. Handen, Elizabeth Head, James E. Hendrix, Ruth Y. Litovsky, André Strydom, Ignacio E. Tapia, Michael S. Rafii	25
15	Early-stage Alzheimer disease: getting trial-ready 2022 ·Nature Reviews Neurology ·Paul Aisen, Gustavo Jimenez‐Maggiora, Michael S. Rafii, Sarah Walter, Rema Raman	74
16	Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD) 2020 ·The Journal of Prevention of Alzheimer s Disease ·Sarah Walter, Taylor Clanton, Oliver Langford, Michael S. Rafii, (unknown), Joshua D. Grill, Gustavo Jimenez‐Maggiora, Reisa A. Sperling, Jeffrey L. Cummings, Paul Aisen	26
17	Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials 2020 ·CNS Drugs ·Michael S. Rafii	17
18	Investigation on Experienced losses in the life story of young people living in Tehran: a phenomenological study 2019 ·SHILAP Revista de lepidopterología ·Michael S. Rafii, (unknown), Ahmad Borjali, (unknown)	3
19	Functional Brain Imaging in the Clinical Assessment of Consciousness 2010 ·PLoS Biology ·Michael S. Rafii, James B. Brewer	5
20	Agrin and microvascular damage in Alzheimer’s disease 2000 ·Neurobiology of Aging ·Tyler M. Berzin, Brian D. Zipser, Michael S. Rafii, V. Kuo-LeBlanc, G.D. Yancopoulos, David J. Glass, Justin R. Fallon, Edward G. Stopa	141

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact